It’s not the finish line, but it’s a step closer to it.

Attorneys general from several states and the plaintiffs’ executive committee in the National Prescription Opiate Litigation MDL this week announced a $26 billion proposed global settlements to resolve lawsuits against Johnson & Johnson and the three largest opioid pharmaceutical distributors AmerisourceBergen Drug Corp., McKesson Corp. and Cardinal Health Inc.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]